Article Name Global/International
Boston Scientific Secures FDA Approval for Expanded Labeling of FARAPULSE™ PFA System
Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology.
08th July, 2025
Alcon to Acquire LumiThera, Expanding Retinal Portfolio with Breakthrough AMD Therapy
Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology
08th July, 2025
Morphic Medical Secures CE Mark for RESET® Endoscopic Therapy Device
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.
08th July, 2025
BioNxt Advances Sublingual Cladribine Program Toward Next Phase for MS Treatment
Innovative thin-film formulation of cladribine moves forward as BioNxt prepares for next-stage development in multiple sclerosis therapy, aiming to enhance patient convenience and treatment adherence.
07th July, 2025
Major U.S. Healthcare System Expands Sectra Partnership to Include Pathology Imaging
Enterprise Imaging Cloud Now Integrates Pathology for Streamlined Cancer Diagnostics and Cross-Disciplinary Collaboration
07th July, 2025
CELFULL Launches Celfavor NADH Microcapsules, Redefining Anti-Aging Innovation
New microencapsulation technology ensures NADH stability and absorption, setting a new benchmark in cellular health and longevity supplements.
07th July, 2025
ReCerf Receives CE Mark, Expanding Access to Advanced Hip Resurfacing in Europe
Ceramic-based hip resurfacing implant gains European regulatory approval, offering patients a bone-preserving, metal-free alternative for hip joint restoration.
04th July, 2025
Thermo Fisher’s NGS-Based Oncomine Dx Express Test Gains FDA Approval
FDA clears assay as companion diagnostic for ZEGFROVY™ and broad tumor profiling, advancing precision oncology diagnostics.
04th July, 2025
Philips Secures FDA Clearance for SmartSpeed Precise, Advancing MRI Speed and Image Precision
Dual AI-Powered Imaging Software Set to Enhance Diagnostic Confidence and Workflow Efficiency in MRI
03rd July, 2025
Medtronic and Philips Forge Strategic Partnership to Expand Access to Advanced Patient Monitoring
Collaboration aims to enhance care delivery by integrating Medtronic’s monitoring solutions with Philips’ ecosystem, driving innovation in hospital and ambulatory care settings globally.
03rd July, 2025
New Horizon Medical Solutions Expands Portfolio with Addition of AmchoPlast™
Strategic product inclusion strengthens company’s position in advanced medical material solutions for healthcare innovation
02nd July, 2025
ZAP Surgical and Ibn Sina Medical Center Partner to Introduce Advanced Non-Invasive Brain Surgery to Africa
Collaboration brings the ZAP-X® Gyroscopic Radiosurgery platform to the continent, expanding access to precise, incision-free brain tumor treatment.
02nd July, 2025
ANA5 Funnel Catheter by ANACONDA Biomed Gets CE Mark, Unlocking New Era in Stroke Thrombectomy
CE Mark Approval Advances Precision Thrombectomy with Vessel-Conforming Design for Improved Stroke Outcomes Across Europe
02nd July, 2025
Medtronic Secures CE Mark for VitalFlow™ ECMO System
Next-Generation Extracorporeal Life Support Platform Set to Transform Critical Care Across Europe
02nd July, 2025
Cognito Therapeutics Completes Enrollment in HOPE Pivotal Trial for Spectris™ AD Therapy
Milestone Marks Progress Toward Potential Non-Invasive Treatment for Alzheimer’s Disease Using Gamma Sensory Stimulation
02nd July, 2025
PathAI Secures FDA Clearance for AISight® Dx Diagnostic Platform
Regulatory Approval Enables AISight® Dx Use in Primary Diagnosis, Advancing AI-Powered Pathology Solutions
01st July, 2025
Autonomix Medical Begins Patient Treatment in PoC 2 Clinical Trial Phase
Follow-On Study Aims to Expand Transvascular Nerve Ablation Technology to Broader Visceral Cancer Pain Indications
01st July, 2025
InterShunt Enrolls First Patient in Groundbreaking Heart Failure Clinical Trial
Study Evaluates Innovative Left Atrial Shunt System for Improving Outcomes in HFpEF Patients
30th June, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer